StemCells, Inc. Initiates World’s First Neural Stem Cell Trial In Spinal Cord Injury

StemCells Inc Press Release StemCells Inc announced today they are initiating a clinical trial using their fetal derived neural progenitor cells for the treatment of spinal cord injuries. Previously the company had reported that their stem cells, called HuCNS-SC, are capable of differentiating into various neural lineage cells including neurons, oligodendrocytes, and astrocytes. The fact…